METABOLITOTROPIC THERAPY IN THE TREATMENT OF PATIENTS WITH THE SECOND STAGE ESS ENTIAL HYPERTENSION COMBINED WITH STABLE ISCHEMIC HEART DISEASE
DOI:
https://doi.org/10.11603/2415-8798.2018.2.9150Keywords:
essential hypertension, ischemic heart disease, metabolism rates, Corvitin, Tivortin.Abstract
In the treatment of arterial hypertension (AH), stable ischemic heart disease (SIHD), correction of metabolic factors of cardiovascular risk using antioxidants and nitrogen monoxide (NO) donor agents is extremely important.
The aim of the study – to investigate the effectiveness of treatment of patients with AH of the II stage in conjunction with SIHD by influencing with Quercetin (Corvitin) and Arginine hydrochloride (Tivortin) upon the lipid and carbohydrate metabolism indices, the intensity of peroxide lipid oxidation (LPO), and the endothelial function.
Materials and Methods. The study involved 56 patients with AH of the II stage concomitant with SIHD, which were randomized into two groups. The 1st group consisted of 24 patients, who received a common baseline therapy (BT). Patients of the 2nd group (32 persons) received infusion Corvitin therapy (0.5 g) besides BT during the first 6 days, and 100 ml of intravenous Tivortin solution during the next 6 days, followed by the outpatient oral administration of 10 ml of Tivortin 2 times per day during two weeks.
Results and Discussion. The use of Corvitin and Tivortin against the background of BT in patients with AH of the II stage in combination with SIHD has led to a significant improvement of lipidogram indices, decreased plasma glucose concentration, immunoreactive insulin (IRI), HOMA -IR index, plasma malonic aldehyde (MA) and erythrocytes. Reliable increase in the content of reduced glutathione (RG), increased activity of glutathione peroxidase (GP), catalase (CT) has been marked from the side of antioxidant protection (AOP). There was a significant increase in the content of end-metabolites of NO by 22.2 %, of the endothelial vascular growth factor VEG F-A – by 38.2 %. A more significant indices dynamics is observed in patients with the genotype Pro/Ala of the PPAR γ2 gene.
References
(2013). Klinichni rekomendatsii z arterialnoi hipertenzii Yevropeiskoho tovarystva hipertenzii (ESH) ta Yevropeiskoho tovarystva kardiolohiv (ESC) 2013 roku [Clinical guidelines for arterial hypertension of the European Society for Hypertension (ESH) and the European Society of Cardiology (ESC) 2013]. Arteryalnaia hypertenzyia – Arterial Hy¬pertension, 4, 61-157 [in Ukrainian].
Huffman, M.D., Lloyd-Jones, D.M., Ning, H., Labarthe, D.R., Castillo М.G., O’Flaherty, М., … Capewell, S. (2013). Epidemiology and Prevention. Quantifying Options for Reducing Coronary Heart Disease Mortality By 2020. Circulation, 127, 5, 2477-2484.
Svishchenko, Ye.P. & Mishchenko, L.A. (2017). Kliniko-demohrafichni kharakterystyky patsiientiv z vpershe vyiavlenoiu arterialnoiu hipertenziieiu: rezultaty doslidzhennia START [Clinical and demographic characteristics of patients with newly diagnosed arterial hypertension: results of the START study]. Ukrainskyi kardiolohichnyi zhurnal – Ukrainian Cardiology Journal, 6, 14-23 [in Ukrainian].
Tseluiko, V.I. & Yakovleva, L.M. (2013). Henetychni aspekty arterialnoi hipertenzii u khvorykh na ishemichnu khvorobu sertsia [Genetic aspects of arterial hypertension in patients with ischemic heart disease]. Arteryalnaia hypertenzyia – Arterial Hy¬pertension, 5[in Ukrainian]. Retrieved from: http://www.mif-ua.com/archive/article/37263
Babak, O.Ya. & Andrieieva, A.O. (2013). Hormonalni zminy v zhyrovii tkanyni khvorykh na hipertonichnu khvorobu i ozhyrinnia [Hormonal changes in adipose tissue of patients with hypertension and obesity]. Ukr. terapevt. zhurnal – Ukrainian Therapeutic Journal, 1, 63-67 [in Ukrainian].
Williams, B., Lacy, P.S. & Thom, S.V. (2006). Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation, 2006, 113, 1213-1225.
Svishchenko, Ye.P. & Mishchenko, L.A. (2011). Znachennia netradytsiinykh faktoriv sertsevo-sudynnoho ryzyku dlia rozvytku i prohresuvannia hipertonichnoi khvoroby [Role of non-traditional factors of cardiovascular risk in the development and progression of hypertonic disease]. Ukrainskyi kardiolohichnyi zhurnal – Ukrainian Cardiology Journal, Addition 1, 16-21 [in Ukrainian].
Sirenko, Yu.M., Rekovets, O.L., Savytskyi, S.Yu. & Pavliuk, Ye.A. (2010). Metabolichnyi syndrom u patsiientiv z arterialnoiu hipertenziieiu ta metabolichni efekty riznykh antyhiper¬tenzyvnykh preparativ [Metabolic syndrome in patients with arterial hypertension and metabolic effects of different antihypertensive drugs]. Arteryalnaia hypertenzyia – Arterial Hy¬pertension, 4, 42-56 [in Ukrainian].
Zharinova, V.Yu., Parasyuk, Ye.I., Samots, I.A. & Benkovskaia, N.N. (2016). Vozmozhnosti povysheniya effektivnosti antigiper¬tenzivnoy terapii: rol donatorov oksida azota [Possibilities to increase efficacy of anti-hypertensive therapy: the role of nitrogen oxide donators]. Zdorovia Ukrainy – Health of Ukraine, 1 (44), 45-46 [in Russian].
Jensen, H.A. & Mehta, J.L. (2016). Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis. Exp. Rev. Cardiovasc. Ther., 14 (9), 1021-1033.
Rajapakse, N.W., Head, G.A. & Kaye, D.M. (2016). Say NO to Obesity-Related Hypertension Role of the L-Arginine–Nitric Oxide Pathway. Hypertension, 67 (5), 813-819.
Matsuzawa, Y., Guddeti, R.R., Kwon, T.G, Lerman, L.O. & Lerman, A. (2015). Secondary Prevention Strategy of Cardiovascular Disease Using Endothelial Function Testing. Circ. J., 79 (4), 685-694.
Biletskyi, S.V., Kovalchuk, L.Iu., Petrynych, O.A. & Kazantseva, Т.V. (2013). Pokaznyky prooksydantno-antyoksydantnoho homeostazu ta vmist monooksydu nitrohenu u krovi khvorykh na hipertonichnu khvorobu v poiednanni z ishemichnoiu khvoroboiu sertsia [Indices of prooxidant-antioxidant homeostasis and the content of nitrogen monoxide in the blood of patients with hypertension in combination with coronary heart disease]. Bukovynskyi medychnyi visnyk – Bukovinsky Medical Bulletin, 3 (67), 2, 125-128 [in Ukrainian].
Boiko, V.V. & Biletskyi, S.V. (2017). Pokaznyky lipidnoho obminu, oksydantno-antyoksydantnoho homeostazu, vmist kintsevykh metabolitiv monooksydu nitrohenu krovi u khvorykh na hipertonichnu khvorobu, komorbidnu z ishemichnoiu khvoroboiu sertsia ta tsukrovym diabetom 2-ho typu [Indices of lipid metabolism, oxidative-antioxidant homeostasis, the content of terminal metabolites of blood nitrogen monoxide in patients with hypertension, comorbid with ischemic heart disease and type 2 diabetes]. Bukovynskyi medychnyi visnyk – Bukovinsky Medical Bulletin, 2 (82), 2, 12-15 [in Ukrainian].
Reznikov, O.H., Polumbryk, O.M., Balon, Ya.H. & Polumbryk, M.O. (2014). Pro- ta antyoksydantna systemy i patolohichni protsesy v orhanizmi liudyny [Pro-and antioxidant systems and pathological processes in the human body]. Visn. NAN Ukrainy – Bulletin of the National Academy of Sciences of Ukraine, 10, 17-29 [in Ukrainian].
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
